Press Release
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announced that as of February 22, 2024, the Company has succeeded manufacturing and marketing approval for the HISCL TARC Assay Kit and the HISCL ANP Assay Kit from Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter, "Shionogi"), and has initiated in-house production.
April 21, 2014 news release: Sysmex to Launch the HISCL™ TARC Assay Kit for Atopic Dermatitis - Allows for Automated Testing in Only 17 Minutes -
|
https://www.sysmex.co.jp/en/news/2014/140421.html |
Generic name (JMDN) |
Th2 chemokine/TARC kit
|
|
Product name | HISCL™ TARC Assay Kit | |
in vitro diagnostics approval number in Japan | 225AAAMX00132000 | |
Intended use |
Measuring the amount of human TARC in serum (to assist in determining the severity of atopic dermatitis and assist in the diagnosis of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS); and to aid in determining the exacerbation risks of SARS-CoV-2-positive patients).
|
|
Manufacturer and seller | Sysmex Corporation | |
Target market | Japan (To be expanded gradually outside Japan) |
|
Launch | Gradually on or after February 22, 2024 |
Generic name (JMDN) |
Atrial natriuretic peptide kit
|
|
Product name | HISCL™ ANP Assay Kit | |
in vitro diagnostics approval number in Japan | 225AAAMX00145000 | |
Intended use |
For measuring the amount of human atrial natriuretic peptide (ANP) in plasma.
|
|
Manufacturer and seller | Sysmex Corporation | |
Target market | Japan (To be expanded gradually outside Japan) |
|
Launch | Gradually on or after February 22, 2024 |
Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide. Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalized medicine and novel treatments, under its long-term vision of "Together for a better healthcare journey." Through its unique technology, solutions, and co-creation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives.
* "Healthcare journey" is a trademark of Sysmex Corporation, registered in Japan.
For more information about Sysmex, please visit www.sysmex.co.jp/en/.
FOLLOW US